![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Li, Qian; Demir, Salih; Rio-Alvarez, Alvaro del; Maxwell, Rebecca; Wagner, Alexandra; Carrillo-Reixach, Juan; Armengol, Carolina; Vokuhl, Christian; Haeberle, Beate; Schweinitz, Dietrich von; Schmid, Irene; Cairo, Stefano und Kappler, Roland
(2022):
Targeting the Unwindosome by Mebendazole Is a Vulnerability of Chemoresistant Hepatoblastoma.
In: Cancers, Bd. 14, Nr. 17, 4196
Cairo, Stefano; Armengol, Carolina; Maibach, Rudolf; Haeberle, Beate; Becker, Kristina; Carrillo-Reixach, Juan; Guettier, Catherine; Vokuhl, Christian; Schmid, Irene; Buendia, Marie-Annick; Branchereau, Sophie; Schweinitz, Dietrich von und Kappler, Roland
(2020):
A combined clinical and biological risk classification improves prediction of outcome in hepatoblastoma patients.
In: European Journal of Cancer, Bd. 141: S. 30-39
Carrillo-Reixach, Juan; Torrens, Laura; Simon-Coma, Marina; Royo, Laura; Domingo-Sabat, Montserrat; Abril-Fornaguera, Jordi; Akers, Nicholas; Sala, Margarita; Ragull, Sonia; Arnal, Magdalena; Villalmanzo, Nuria; Cairo, Stefano; Villanueva, Alberto; Kappler, Roland; Garrido, Marta; Guerra, Laura; Sabado, Constantino; Guillen, Gabriela; Mallo, Mar; Pineyro, David; Vazquez-Vitali, Maria; Kuchuk, Olga; Elena Mateos, Maria; Ramirez, Gema; Lopez Santamaria, Manuel; Mozo, Yasmina; Soriano, Aroa; Grotzer, Michael; Branchereau, Sophie; Garcia de Andoin, Nagore; Lopez-Ibor, Blanca; Lopez-Almaraz, Ricardo; Antonio Salinas, Jose; Torres, Barbara; Hernandez, Francisco; Javier Uriz, Jose; Fabre, Monique; Blanco, Julia; Paris, Claudia; Bajciova, Viera; Laureys, Genevieve; Masnou, Helena; Clos, Ariadna; Belendez, Cristina; Guettier, Catherine; Sumoy, Lauro; Planas, Ramon; Jorda, Mireia; Nonell, Lara; Czauderna, Piotr; Morland, Bruce; Sia, Daniela; Losic, Bojan; Buendia, Marie Annick; Rosa Sarrias, Maria; Llovet, Josep M. und Armengol, Carolina
(2020):
Epigenetic footprint enables molecular risk stratification of hepatoblastoma with clinical implications.
In: Journal of Hepatology, Bd. 73, Nr. 2: S. 328-341